A month has gone by since the last earnings report for Krystal Biotech, Inc. (KRYS). Shares have added about 6.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...
Background Bronchoalveolar lavage (BAL) is essential in determining the efficacy of novel therapies in alpha-1 antitrypsin deficiency (AATD). These require initial proof-of-concept demonstration that ...
A medical expert has shed light on a condition that leaves sufferers 'gasping for air', with an estimated 600,000 people in the UK undiagnosed. As the nation battles 'the lurgy', marked by runny noses ...
(NASDAQ:FATE) recently reported positive data from its phase 1 autoimmunity study using FT819 for the treatment of patients ... service on Seeking Alpha Marketplace. If you like what you read ...
While there’s no cure, treatments like inhalers (which open ... However, genetic factors, like alpha-1 antitrypsin deficiency, can also lead to COPD, even in non-smokers. This genetic form ...
highlighting significant advancements in its innovative cancer treatment technology, Alpha DaRT. The company’s participation in the FDA’s TAP program and progress in clinical trials for ...
Sony is expanding its camera range with the Alpha 1 II, a full-frame mirrorless camera with automatic AI subject recognition and improved functions. The Alpha 1 II is the new full-frame flagship ...